0001209191-21-026247.txt : 20210409 0001209191-21-026247.hdr.sgml : 20210409 20210409163631 ACCESSION NUMBER: 0001209191-21-026247 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210408 FILED AS OF DATE: 20210409 DATE AS OF CHANGE: 20210409 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Legault Pierre CENTRAL INDEX KEY: 0001391045 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38916 FILM NUMBER: 21818246 MAIL ADDRESS: STREET 1: P.O. BOX 1028 STREET 2: C/O STONE MANAGEMENT LLC CITY: BERWYNE STATE: PA ZIP: 19312 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BICYCLE THERAPEUTICS plc CENTRAL INDEX KEY: 0001761612 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: B900 BABRAHAM RESEARCH CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB22 3AT BUSINESS PHONE: 011441223261503 MAIL ADDRESS: STREET 1: B900 BABRAHAM RESEARCH CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB22 3AT FORMER COMPANY: FORMER CONFORMED NAME: BICYCLE THERAPEUTICS Ltd DATE OF NAME CHANGE: 20181212 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-04-08 0 0001761612 BICYCLE THERAPEUTICS plc BCYC 0001391045 Legault Pierre C/O BICYCLE THERAPEUTICS PLC B900, BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT UNITED KINGDOM 1 0 0 0 Ordinary Shares 2021-04-08 4 M 0 24838 8.74 A 24838 D Ordinary Shares 2021-04-08 4 S 0 12500 32.00 D 12338 D Ordinary Shares 2021-04-08 4 S 0 12099 31.40 D 239 D Ordinary Shares 2021-04-08 4 S 0 239 32.13 D 0 D Stock Option (Right to Buy) 8.74 2021-04-08 4 M 0 24838 0.00 D 2029-04-25 Ordinary Shares 24838 173312 D This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.37265 to GBP 1.00 as of April 8, 2021. Shares were sold pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.98 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (4). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.09 to $32.16 inclusive. This option shall vest in 36 equal monthly installments and shall be fully vested on March 15, 2022. /s/ Lee Kalowski, Attorney-in-Fact 2021-04-09